Medication Support for Women with Dysmenorrhea Using Shift P

「As part of its initiatives to promote women’s participation in the workplace, in April 2022 the company and 15 group companies introduced the Shift P Medication Support Program to support low-dose oral contraceptive use by female employees experiencing dysmenorrhea and other conditions. Under this program, the company subsidizes consultation and medication costs incurred when low-dose oral contraceptives are prescribed, with the aim of providing a workplace environment in which employees can work in good physical and mental health.」

「We launched Shift P, a medication support project for women with dysmenorrhea, together with 株式会社エムティーアイ (Shinjuku-ku, Tokyo), and opened a dedicated website (https://shiftp.lnln.jp/) in November 2020.」

「We also launched Shift P, a medication support project for women with dysmenorrhea, together with 株式会社エムティーアイ (Shinjuku-ku, Tokyo), and opened a dedicated website (https://shiftp.lnln.jp/) in November 2020. Through accurate information on low-dose oral contraceptives, initiatives to promote understanding and medication support, we aim to help create a society in which as many women as possible can live healthier lives in a way that suits them.」